Christine Burnett

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Molecular Templates (United States)(Current)

University of Arizona

Levine Cancer Institute

Memorial Sloan Kettering Cancer Center

Christine Burnett is an author at Molecular Templates (United States) specializing in recombinant fusion proteins, tumor response evaluation, and chemotherapy in hematologic malignancies.

Publications per year

2018–2022

Publications

Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma

Paul A. Hamlin, Vasile Musteata, Steven I. Park et al. · Cancer Research Communications · 2022 · 12 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety and efficacy of anti-CD20 immunotoxin MT-3724 in relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) in a phase I study.

Michelle A. Fanale, Paul A. Hamlin, Steven I. Park et al. · Journal of Clinical Oncology · 2018 · 10 citations

Medicine, Oncology, Pharmacology +16

1–2 of 2